News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synageva BioPharma (GEVA) Announces Data Presentations At The 10th Annual Lysosomal Disease Network (LDN) World Symposium



1/29/2014 7:52:58 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today announced data presentations at the upcoming LDN WORLD Symposium being held February 11-13 in San Diego, California, including three oral presentations and three posters describing sebelipase alfa, lysosomal acid lipase deficiency (LAL Deficiency), and SBC-103 for MPS IIIB.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES